There is a new sector in the clinical laboratory industry. It is called “global direct-to-consumer (DTC) genetic health testing” by Kalorama Information, a market research firm based in Rockville, Md. In a recent report, Kalorama says this sector is comprised of the direct-to-consumer genetic tests which are initiated by the consumer, meaning that the consumer decides and orders the genetic tests. According to Kalorama, during 2017, revenue in this sector totalled $99 million and the company predicts it will top $310 million by 2022. It also predicts that government regulation of DTC genetic tests will ease during the next four years and that will stimulate growth in this sector.
MORE ON: DTC Testing
Kalorama identifies 23andMe as the leader in this market sector. It lists other key players offering DTC genetic tests as EasyDNA of Elk Grove, Calif.; Eastern Biotech and Life Sciences of Dubai, UAE; and, Mapmygenome of Madhapur, Hyderabad, India.
APPLE TO DEVELOP CHIPS FOR HEALTH INFORMATION
Apple is developing a custom chip that would specifically handle health information tracking and related applications. On August 14, MDLinx reported that Apple’s Health Sensing hardware team was hiring engineers for this project. The Apple iPhone and watch currently have health monitoring features. MDLinxsaid that, by designing a custom chip, Apple could better protect its intellectual property. Another goal would be to design a chip function that could continuously monitor blood sugar. Also competing in this market segment are Alphabet (parent of Google), Amazon, and Microsoft.
- Paul Mango was appointed Chief Principal Deputy Administrator and Chief of Staff at the Center for Medicare and Medicaid Services. Earlier this year, Mango was a candidate for the Governor of Pennsylvania. Previously, Mango held executive positions at McKinsey and Company and The Institute for Transfusion Medicine.
- Anne T. Daley now serves as the Quality Officer for ARUP Laboratories. She formerly worked with Daley Consulting, Chi Solutions, Ascendium, Roche Diagnostics, University of Phoenix, Sonora Laboratory Services, Maricopa Health, and Hartford Memorial Hospital.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, September 10, 2018.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…research at the Mayo Clinic that demonstrated the potential of telomeres to be useful biomarkers that clinical laboratories could eventually use to help physicians diagnose a number of diseases and health conditions.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.